EU-project to find new biomarkers in respiratory disease
17 June 2016
The Swedish-Danish project Breathe has recently been granted € 3.5 million from the Interreg Fund Öresund-Kattegat-Skagerrak.
The goal of the project is to find new biomarkers that can indicate which biological drugs have an effect on certain types of asthma and COPD. The project has been initiated due to the recent increase in the use of several biological drugs, i.e drugs based on proteins or anti-bodies, in respiratory medicine. The new funds will also allow for the establishment of a biobank and patient database with approximately 500-800 patients with various forms of asthma and COPD. The biobank and the database will be available for pharmaceutical companies that want to do clinical trials inthese areas. The 3-year project kicks off in fall 2016 and involves partners from Denmark and Southern
Sweden: University of Copenhagen
, Lund University
, Skåne University Hospital
, Næstved Hospital and Bispebjerg Hospital.
Read more about the project here (in Danish)